EMEA-000298-PIP01-08-M06
Key facts
| Invented name |
Pegasys
|
| Active substance |
peginterferon alfa-2a
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0143/2018
|
| PIP number |
EMEA-000298-PIP01-08-M06
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Roche Registration GmbH
Tel. +41 6168 79411 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000298-PIP01-08-M06
|
| Compliance opinion date |
29/05/2019
|
| Compliance outcome |
positive
|